The disease (syndrome) of Marchiafava-Bignami


如何引用文章

全文:

详细

The article considers etiopathogenetic, clinical, diagnostic and therapeutic aspects (characteristics) of disease (syndrome) of Marchiafava-Bignami. It is emphasized that this condition in most of the cases is related to chronic alcoholism though it can occur and under other diseases (diabetes mellitus, sepsis, etc.). Despite to previous opinion about inevitable lethality of disease (syndrome) of Marchiafava-Bignami, broad implementation in clinical practice of methods of neurovisualisation and especially NMR technique, demonstrated that this disease can have not so negative prognosis, It is not excluded that in medical clinical practice more light forms of disease (syndrome) of Marchiafava-Bignami are not diagnosed. The differentiated diagnostic is implemented in relation to a number of neurological diseases, including acute disorders of cerebral circulation, lymphoma, multiple sclerosis. The results of NMR of brain play major role in proper diagnostic of disease (syndrome) of Marchiafava-Bignami. The treatment of disease requires vitamins of group B, especially vitamin B1 (thiamine) and corticosteroids. However, estimate of effectiveness of similar treatment requires further investigations.

作者简介

Igor’ Damulin

The I.M. Sechenov first Moscow state medical university of Minzdrav of Russia

Email: damulin@mmascience.ru
doctor of medical sciences, professor, of the chair of nervous diseases and neurosurgery of the medical faculty the I.M. Sechenov first Moscow state medical university of Minzdrav of Russia 119435, Moscow

A. Strutsenko

The peoples' friendship university of Russia

Кафедра нервных болезней и нейрохирургии 110000 Moscow, Russian Federation

参考

  1. Demaerel P., Van Paesschen W. Marchiafava-Bignami disease. N. Engl. J. Med. 2004; 351: e10.
  2. Folescu R., Zamfir C.L., Sisu A.M., Motoc A.G., Ilie A.C., Moise M. Histopathological and imaging modifications in chronic ethanolic encephalopathy. Rom. J. Morphol. Embryol. 2014; 55: 797-801.
  3. Gerlach A., Oehem E., Wittchow J., Ziyeh S., Glocker F.X., Els T. Use of high-dose cortisone in patient with Marchiafava-Bignami disease. J. Neurol. 2003; 250: 758-60.
  4. Heinrich A., Runge U., Khaw A.V. Clinicoradiologic subtypes of Marchiafava-Bignami disease. J. Neurol. 2004; 251: 1050-9.
  5. Gambini A., Falini A., Moiola L., Comi J., Scotti G. Marchiafava-Bignami disease: longitudinal MR imaging and MR spectroscopy study. AJNR Am. J. Neuroradiol. 2003; 24(2): 249-53.
  6. Helenius J., Tatlisumak T., Soinne S., Valanne L., Kaste M. Marchiafava-Bignami disease: two cases with favourable outcome. Eur. J. Neurol. 2001; 8: 269-72.
  7. Namekawa M., Nakamura Y., Nakano I. Cortical Involvement in Marchiafava-Bignami disease can be a predictor of a poor prognosis: a case report and review of the literature. Intern. Med. 2013; 52(7): 811-3.
  8. Hoshino Y., Ueno Y., Shimura H., Miyamoto N., Watanabe M., Hattori M., Urabe T. Marchiafava-Bignami disease mimics motor neuron disease: case report. BMC Neurol. 2013; 13: 208.
  9. Hillbom M., Saloheimo P., Fujioka S., Wszolek Z.K., Juvela S., Leone M.A. Diagnosis and management of Marchiafava-Bignami disease: a review of CT/MRI confirmed cases. J. Neurol., Neurosurg. Psychiatry. 2014; 85(2): 168-73.
  10. Rickert C.H., Karger B., Varchmin-Schultheiss K., Varchmin-Schultheiß K., Brinkmann B., Paulus W. Neglect-associated fatal Marchiafava-Bignami disease in a non-alcoholic woman. Int. J. Legal Med. 2001; 115(2): 90-3.
  11. Cui Y., Zheng L., Wang X., Zhang W., Yuan D., Wei Y. Marchiafava-Bignami disease with rare etiology: A case report. Exp. Ther. Med. 2015; 9(4): 1515-7.
  12. Jorge J.M., Gold M., Sternman D., Prabhakaran K., Yelon J. Marchiafava-Bignami disease in a trauma patient. J. Emerg. Trauma Shock. 2015; 8(1): 52-4.
  13. Yoshizaki T., Hashimoto T., Fujimoto K., Oguchi K. Evolution of callosal and cortical lesions on MRI in Marchiafava-Bignami disease. Case Rep. Neurol. 2010; 2(1): 19-23.
  14. Garcia-Santibanez R. Marchiafava-Bignami disease presenting as acute dysarthria and ataxia. Alcohol Alcohol. 2014; 50(2): 256-7.
  15. Johkura K., Naito M., Naka T. Cortical Involvement in Marchiafava-Bignami disease. AJNR Am. J. Neuroradiol. 2005; 26(3): 670-3.
  16. Ruiz-Martinez J., Perez-Balsa A.M., Ruibal M., Urtasun M., Villanua J., Marti Masso J.F. Marchiafava-Bignami disease with widespread extracallosal lesions and favourable course. Neuroradiology. 1999; 41(1): 40-3.
  17. Bhat A., Punia V., Lee H.J., Marks D. Corpus callosum fibre disruption in Marchiafava-Bignami disease. Pract. Neurol. 2014; 14(3): 189-90.
  18. Kumar S., Challam R., Naveen J., Singh W.J. Marchiafava-Bignami disease: A case report. J. Clin. Diagn. Res. 2014; 8(8): RD01-2.
  19. Bano S., Mehra S., Yadav S.N., Chaudhary V. Marchiafava-Bignami disease: Role of neuroimaging in the diagnosis and management of acute disease. Neurol. India. 2009; 57(5): 649-52.
  20. Ferracci F., Conte F., Gentile M., Candeago R., Foscolo L., Bendini M. et al. Marchiafava-Bignami disease: Computed tomograghic scan, 99mTc HMPAO-SPECT, and FLAIR MRI findings in a patient with subcortical aphasia, alexia, bilateral agraphia, and left-handed deficit of constructional ability. Arch. Neurol. 1999; 56(1): 107-10.
  21. Tung C.S., Wu S.L., Tsou J.C., Hsu S.P., Kuo H.C., Tsui H.W. Marchiafava-Bignami disease with widespread lesions and complete recovery. AJNR Am. J. Neuroradiol. 2010; 31(8): 1506-7.
  22. Hayashi T., Tanohata K., Kunimoto M., Inoue K. Marchiafava-Bignami disease with resolving symmetrical putaminal lesion. J. Neurol. 2002; 249(2): 227-8.
  23. Kim M.J., Kim J.K., Yoo B.G., Kim K.S., Jo Y.D. Acute Marchiafava-Bignami Disease with widespread callosal and cortical lesions. J. Korean Med. Sci. 2007; 22(5): 908-11.
  24. Meneegon P., Sibon I., Pachai C., Orgogozo J.M., Dousset V. Marchiafava-Bignami disease: Diffusion-weighted MRI in corpus callosum and cortical lesions. Neurology. 2005; 65: 475-7.
  25. Dujmovic I., Nikolic I., Gavric-Kezic M., Dackovic J., Mesaros S., Drulovic J. Reversible widespread brain MRI lesions in Marchiafava-Bignami disease. Neurology. 2015; 84: e81-2.
  26. Ihn Y.K., Hwang S.S., Park Y.H. Acute Marchiafava-Bignami disease: diffusion-weighted MRI in cortical and callosal involvement. Yonsei Med. J. 2007; 48(2): 321-4.
  27. Iwai T., Matsuo K., Morii-Kitani F., Azuma F., Matsuo H., Takada M. et al. Marchiafava-Bignami disease with hyperintensity on late diffusion-weighted imaging. Acta Radiol. Short Rep. 2014; 3(7): 1-4.
  28. Yang L., Qin W., Xu J.H., Hu W.L. Marchiafava-Bignami disease with asymmetric extracallosal lesions. Arch. Med. Sci. 2015; 11: 895-8.
  29. Sano M., Ishii K., Suzuki T., Uchigata M., Senda M. Reductions in the bilateral parietal and occipital cerebral blood flow and metabolism in a patient with Marchiafava-Bignami disease. J. Neurol. 1999; 246: 607-8.
  30. Lucato L.T., Freua F., Kok F. Chronic stage of Marchiafava-Bignami disease. Arq. Neuropsiquiatr. 2015; 73(10): 890.
  31. Lakatos A., Kosta P., Konitsiotis S., Zikou A.K., Astrakas L.G., Argyropoulou M.I. Marchiafava-Bignami disease. An acquired callosotomy. Neurology. 2014; 83: 1219.
  32. Nemlekar S.S., Mehta R.Y., Dave K.R., Shah N.D. Marchiafava-Bignami disease treated with parenteral thiamine. Indian J. Psychol. Med. 2016; 38(2): 147-9.
  33. Pinto M.V., Bon A., Costa V.C., Noro F., Lima M.A. Marchiafava-Bignami disease in an AIDS patient. Arq. Neuropsiquiatr. 2016; 74(2): 180.
  34. Augusto L., Figueiredo R., Costa H., Reis C., Silva M.L. Marchiafava-Bignami disease as a cause of visual hallucinations. Rev. Bras. Psiquiatr. 2015; 37(1): 82-3.
  35. Kilinc O., Ozbek D., Ozkan E., Midi I. Neurological and psychiatric findings of Marchiafava-Bignami disease in a nonalcoholic diabetic patient with high blood glucose levels. J. Neuropsychiatry Clin. Neurosci. 2015; 27(2): e149-50.
  36. Suzuki Y., Oishi M., Ogawa K., Kamei S. A patient with Marchiafava-Bignami disease as a complication of diabetes mellitus treated effectively with corticosteroid. J. Clin. Neurosci. 2012; 19: 761-2.
  37. Wenz H., Eisele P., Artemis D., Forster A., Brockmann M.A. Acute Marchiafava-Bignami disease with extensive diffusion restriction and early recovery: case report and review of the literature. J. Neuroimaging. 2014; 24(4): 421-4.

版权所有 © Eco-Vector, 2016


 


##common.cookie##